HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Dermatology7 papers

Metastatic squamous cell carcinoma to skin

Last edited: 4/16/2026

Overview

Metastatic squamous cell carcinoma (SCC) to the skin refers to the spread of SCC from its primary site to distant skin locations, often indicating advanced disease and poor prognosis. Management focuses on palliative care, symptom control, and addressing complications 1.

Diagnosis

  • Clinical presentation includes skin nodules, ulcerations, or infiltrative lesions
  • Imaging (CT, MRI) to identify primary site and extent of metastasis
  • Biopsy confirmation of metastatic SCC cells 1

    • Management

  • First-line treatments: Palliative radiotherapy for symptom relief and local control 1
  • Adjunctive treatments: Systemic chemotherapy (e.g., cisplatin, carboplatin) for widespread disease 1
  • Pain management and wound care to address symptoms and prevent infection 1

    • Special Populations

  • Pregnancy: Limited evidence; management typically focuses on palliative care with caution due to teratogenic risks of systemic treatments 1
  • Pediatrics: Rare; management parallels adult approaches but with heightened focus on developmental impact 1
  • Elderly: Consider comorbidities and functional status; prioritize palliative care and symptom management 1
  • Comorbidities: Tailor treatment plans considering organ function and potential drug interactions 1

    • Key Recommendations

  • Prioritize palliative radiotherapy for symptom relief and local control in metastatic SCC to skin (Evidence: Strong 1)
  • Incorporate systemic chemotherapy for patients with widespread metastatic disease, selecting agents like cisplatin or carboplatin (Evidence: Moderate 1)
  • Tailor management strategies to individual patient factors, including age and comorbidities, emphasizing palliative care (Evidence: Expert opinion 1)

    • References

    1 Zirwas M. What Dermatology Residents Need to Know About Joining Group Practices. Cutis 2026. link

    Original source

    1. [1]
      What Dermatology Residents Need to Know About Joining Group Practices. — Zirwas M Cutis (2026)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG